OSTX Neutral Sentiment
OS Therapies Provides First Half 2026 Corporate Outlook
Key Takeaway: OS Therapies has released its corporate outlook for the first half of 2026. The announcement provides insights into the company's strategic direction and anticipated developments during this period. Specific details regarding product launches or financial projections were not disclosed in the article.
Price reaction · baseline $1.34 (2026-01-02 close) · hit pre-market · clean, no other OSTX news in the window
day 0 close
+7.5%
day 1
+10.4%
day 3 · peak
+14.9%